Pfizer announces The Lancet Neurology has published Phase 3 data for zavegepant for the acute treatment of migraine in adults
- Details
- Category: Pfizer
![Pfizer Pfizer](/images/logo/pfizer.png)
Roche announces donation of essential medicines and diagnostic solutions to the people affected by the devastating earthquake in Türkiye and Syria
- Details
- Category: Roche
![Roche Roche](/images/logo/roche.png)
Kerendia™ (finerenone) granted expanded indication in the EU for broad range of patients with chronic kidney disease and type 2 diabetes
- Details
- Category: Bayer
![Bayer Bayer](/images/logo/bayer.png)
GSK announces results from 17-year retrospective study on US clinical trial diversity
- Details
- Category: GlaxoSmithKline
![GlaxoSmithKline GlaxoSmithKline](/images/logo/gsk.png)
2022 Otto Bayer Award goes to Professor Frank Glorius
- Details
- Category: Bayer
![Bayer Bayer](/images/logo/bayer.png)
Pfizer reports record full-year 2022 results
- Details
- Category: Pfizer
![Pfizer Pfizer](/images/logo/pfizer.png)
AMJEVITA™ (adalimumab-atto), first biosimilar to Humira® now available in the United States
- Details
- Category: Amgen
![Amgen Amgen](/images/logo/amgen.png)
More Pharma News ...
- CHMP recommends Bayer’s darolutamide for the treatment of metastatic hormone-sensitive prostate cancer
- Roche announces the European Commission approval of Xofluza for the treatment and prevention of influenza in children aged one year and above
- Pfizer expands 'An Accord for a Healthier World' product offering to include full portfolio for greater benefit to 1.2 billion people in 45 lower-income countries
- Acquisition of Neogene Therapeutics completed
- Bayer to accelerate drug discovery with Google Cloud's high-performance compute power
- NextPoint Therapeutics announces $80 million Series B financing co-led by Leaps by Bayer and Sanofi Ventures to advance novel immuno-oncology programs
- AstraZeneca to acquire CinCor Pharma to strengthen cardiorenal pipeline